|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Assets subject to assignment for the benefit of creditors, current portion | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Restricted cash and cash equivalents | ||||||||||||||||||||
| Long-term deposits | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Investment in affiliate | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Prepayment - long-term supply agreement | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Assets subject to assignment for the benefit of creditors | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and stockholders' equity | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Finance lease liabilities, current | ||||||||||||||||||||
| Debt and finance lease liabilities, current | ||||||||||||||||||||
| Liabilities subject to assignment for the benefit of creditors, current portion | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Finance lease liabilities | ||||||||||||||||||||
| Long-term debt and finance lease liabilities, net of current portion | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Warrant liability | ||||||||||||||||||||
| Estimated liability - guarantee of obligation of unconsolidated affiliate | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Deferred tax liabilities, net | ||||||||||||||||||||
| Liabilities subject to assignment for the benefit of creditors | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Common stock issued for investment in affiliates including common stock subject to Put Right | ||||||||||||||||||||
| Stockholders' equity | ||||||||||||||||||||
| Preferred stock, $0.0001 par value, 150,000,000 shares authorized, no shares issued and outstanding as of December 31, 2024 and 2023 | ||||||||||||||||||||
| Common stock, $0.0001 par value, 1,000,000,000 and 1,600,000,000 shares authorized as of December 31, 2024 and 2023, respectively, 115,639,591 and 44,336,100 shares issued and outstanding as of December 31, 2024 and 2023, respectively (1) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
